HomeOther

    Other

    MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

    This Post Was Syndicated Under License Via QuoteMedia   Canada NewsWire First-in-human trial to investigate the tolerability, pharmacology, and pharmacokinetics of novel MDMA-like compounds versus a placebo in healthy subjects Acute effects of equivalent doses will be compared across the following compounds: MDMA, MDA, Lys-MDMA and Lys-MDA NEW...

    Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’s Heart Health and Overall Health Exclusively on Amazon

    This Post Was Syndicated Under License Via QuoteMedia LAS VEGAS, Sept. 20, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has introduced Whitney Johns ’ premium heart health supplement, Citrus Bergamot for Women , now available exclusively...

    MindMed Announces Compliance with Nasdaq Listing Requirements

    This Post Was Syndicated Under License Via QuoteMedia   Canada NewsWire NEW YORK , Sept. 14, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it has received...

    Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior...

    This Post Was Syndicated Under License Via QuoteMedia   PR Newswire - Acadia Healthcare is the Largest Stand-Alone Behavioral Health Company in the United States Operating a Network of Nearly 240 Behavioral Health Facilities in 39 States and Puerto Rico NEW YORK , Sept. 13, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a...

    Keep exploring

    MindMed Announces Compliance with Nasdaq Listing Requirements

    This Post Was Syndicated Under License Via QuoteMedia   Canada NewsWire NEW YORK , Sept. 14, 2022 /CNW/ -- Mind...

    Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior...

    This Post Was Syndicated Under License Via QuoteMedia   PR Newswire - Acadia Healthcare is the Largest...

    Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference

    Disclaimer   PR Newswire NEW YORK , Sept. 9, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical...

    atai Life Sciences to Participate in September Investor Events

    Disclaimer NEW YORK and BERLIN, Sept. 07, 2022 (GLOBE NEWSWIRE) -- atai Life Sciences N.V....

    Red Light Holland Announces Live Investor Q&A Session at 2:00 PM (EST) on Thursday, September 8, 2022

    Disclaimer Toronto, Ontario--(Newsfile Corp. - September 2, 2022) - Red Light Holland Corp. (CSE: TRIP)...

    Seelos Therapeutics to Participate in Two Upcoming Psychedelic Conferences

    Disclaimer   PR Newswire - Seelos' SLS-002 is currently being developed specifically to treat the symptoms of...

    Red Light Holland Reports First Quarter 2022 Financial Results

    Disclaimer Cash balance of $23.0 million as at June 30, 2022 Revenue of $785...

    MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder

    Canada NewsWire NEW YORK , Aug. 25, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the "Company"...

    Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson’s Research for SLS-004

    Disclaimer   PR Newswire SLS-004 Utilizes CRISPR-dCas9 to Target the SNCA Gene Responsible for the Expression of Alpha-Synuclein NEW...

    Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth

    Disclaimer LAS VEGAS, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator...

    Red Light Holland to Acquire Two Wellness Shops in the Netherlands: SmartShop Utrecht and SmartShop OSS

    Acquisition of SmartShops provide Red Light Holland with full vertical integration from production, packaging,...

    MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference

      Canada NewsWire NEW YORK , Aug. 2, 2022 /CNW/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED),...

    Latest News

    MindMed Collaborators Dose First Patient in Phase 1 Investigator-Initiated Trial of MDMA-Like Substances

    This Post Was Syndicated Under License Via QuoteMedia   Canada NewsWire First-in-human trial to investigate the tolerability,...

    Healthy Extracts Launches Whitney Johns Citrus Bergamot for Women’s Heart Health and Overall Health Exclusively on Amazon

    This Post Was Syndicated Under License Via QuoteMedia LAS VEGAS, Sept. 20, 2022 (GLOBE NEWSWIRE)...

    MindMed Announces Compliance with Nasdaq Listing Requirements

    This Post Was Syndicated Under License Via QuoteMedia   Canada NewsWire NEW YORK , Sept. 14, 2022 /CNW/ -- Mind...

    Seelos Therapeutics Announces the Participation of Acadia Healthcare in the Registration Directed Study of SLS-002 (Intranasal Racemic Ketamine) for Acute Suicidal Ideation and Behavior...

    This Post Was Syndicated Under License Via QuoteMedia   PR Newswire - Acadia Healthcare is the Largest...